Inari Medical Inc (NARI)
81.49
-3.43 -4.04%
NASDAQ
Nov 26, 16:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 242.38M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.27 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 15.72M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 90.35% |
| Profit Margin (Quarterly) | -3.85% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 4.091B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 18.30 |
| PE Ratio | 301.81 |
| Price to Book Value | 17.46 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -10.33M |
| Return on Equity | Upgrade |
View All NARI News
News
-
WireHeadlineTime (ET)
-
MT Newswires11/10 15:56
-
MT Newswires11/10 11:21
-
MT Newswires11/10 11:01
-
Yahoo11/10 07:32
-
Yahoo11/10 05:02
-
Yahoo11/09 18:15
-
SA Breaking News11/09 18:00
-
SA Breaking News11/09 16:16
-
MT Newswires11/09 16:08
-
Yahoo11/09 16:01
-
Yahoo11/03 11:03
-
Yahoo11/02 15:02
-
Yahoo10/28 08:01
-
Yahoo10/26 16:01
-
Yahoo10/21 11:18
-
Yahoo10/20 08:00
-
Yahoo10/18 08:00
-
Yahoo10/18 04:20
-
MT Newswires10/12 16:52
-
MT Newswires10/08 09:26
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/09/2022 | Earnings Results | Q4 2021 Earnings Results |
| 03/09/2022 16:30 EST | Earnings Calls | Q4 2021 Earnings Call |
| 11/09/2021 | Earnings Results | Q3 2021 Earnings Results |
| 11/09/2021 16:30 EST | Earnings Calls | Q3 2021 Earnings Call |
| 08/10/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/10/2021 16:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 05/27/2021 | AGM | 2020 Annual General Meeting |
| 05/11/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/11/2021 16:30 EST | Earnings Calls | Q1 2021 Earnings Call |
| 03/09/2021 | Earnings Results | Q4 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States.
- URL: https://www.inarimedical.com
- Investor Relations URL: https://ir.inarimedical.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Medical Devices
- Equity Style: Small Cap/Growth
- Next Earnings Release: Mar. 09, 2022
- Last Earnings Release: Nov. 09, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 81.49 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| DFZRX | Delaware Smid Cap Growth R6 | 4.38% |
| DSGFX | Delaware Small Cap Growth R | 4.32% |
| CSMVX | Congress Small Cap Growth Retail | 2.65% |
| JSML | Janus Henderson Small Cap Gr Alpha ETF | 2.19% |
| EGWDX | Wells Fargo Fundamental Sm Cap Gr Adm | 1.49% |
| XHE | SPDR® S&P Health Care Equipment ETF | 1.44% |
| JSMD | Janus Henderson Small/Md Cp Gr Alpha ETF | 1.19% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NARI Tweets Stocktwits
Advertisement
